Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aram F Hezel

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Nature|July 22, 2014
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancerSupriya K Saha, Christine A Parachoniak, Krishna S Ghanta, et al.
JAMA Network Open|January 9, 2024
Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical TrialHannah M Thompson, Dana M Omer, Sabrina Lin, et al.
Cancer Discovery|October 11, 2011
PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine networkHaoqiang Ying, Kutlu G Elpek, Anant Vinjamoori, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2008
Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancerAlec C Kimmelman, Aram F Hezel, Andrew J Aguirre, et al.
Cancer|April 20, 2026
Phase 2 trial of exercise and low-dose ibuprofen for cancer-related cognitive impairment in patients receiving chemotherapyMichelle C Janelsins, Riham A Alieldin, Tyler Holler, et al.
Gut|August 20, 2021
GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunityLuis I Ruffolo, Katherine M Jackson, Peyton C Kuhlers, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 30, 2020
Insulin-Like Growth Factor-1 Receptor Expression and Disease Recurrence and Survival in Patients with Resected Pancreatic Ductal AdenocarcinomaChunxia Du, Annacarolina da Silva, Vicente Morales-Oyarvide, et al.
Cell|May 1, 2012
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolismHaoqiang Ying, Alec C Kimmelman, Costas A Lyssiotis, et al.
Cancer Discovery|May 28, 2016
Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic CholangiocarcinomaSupriya K Saha, John D Gordan, Benjamin P Kleinstiver, et al.
Cell|April 19, 2020
Endocrine-Exocrine Signaling Drives Obesity-Associated Pancreatic Ductal AdenocarcinomaKatherine Minjee Chung, Jaffarguriqbal Singh, Lauren Lawres, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Nature|July 22, 2014
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancerSupriya K Saha, Christine A Parachoniak, Krishna S Ghanta, et al.
JAMA Network Open|January 9, 2024
Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical TrialHannah M Thompson, Dana M Omer, Sabrina Lin, et al.
Cancer Discovery|October 11, 2011
PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine networkHaoqiang Ying, Kutlu G Elpek, Anant Vinjamoori, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2008
Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancerAlec C Kimmelman, Aram F Hezel, Andrew J Aguirre, et al.
Cancer|April 20, 2026
Phase 2 trial of exercise and low-dose ibuprofen for cancer-related cognitive impairment in patients receiving chemotherapyMichelle C Janelsins, Riham A Alieldin, Tyler Holler, et al.
Gut|August 20, 2021
GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunityLuis I Ruffolo, Katherine M Jackson, Peyton C Kuhlers, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 30, 2020
Insulin-Like Growth Factor-1 Receptor Expression and Disease Recurrence and Survival in Patients with Resected Pancreatic Ductal AdenocarcinomaChunxia Du, Annacarolina da Silva, Vicente Morales-Oyarvide, et al.
Cell|May 1, 2012
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolismHaoqiang Ying, Alec C Kimmelman, Costas A Lyssiotis, et al.
Cancer Discovery|May 28, 2016
Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic CholangiocarcinomaSupriya K Saha, John D Gordan, Benjamin P Kleinstiver, et al.
Cell|April 19, 2020
Endocrine-Exocrine Signaling Drives Obesity-Associated Pancreatic Ductal AdenocarcinomaKatherine Minjee Chung, Jaffarguriqbal Singh, Lauren Lawres, et al.
Pageof 7